Advertisement
Singapore markets open in 2 hours 41 minutes

  • Straits Times Index

    3,292.93
    -3.96 (-0.12%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • Dow

    38,675.68
    +449.98 (+1.18%)
     

  • Nasdaq

    16,156.33
    +315.33 (+1.99%)
     

  • Bitcoin USD

    63,769.24
    +47.52 (+0.07%)
     

  • CMC Crypto 200

    1,327.76
    +50.78 (+3.98%)
     

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • Gold

    2,311.30
    +2.70 (+0.12%)
     

  • Crude Oil

    78.38
    +0.27 (+0.35%)
     

  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     

  • Nikkei

    38,236.07
    -38.03 (-0.10%)
     

  • Hang Seng

    18,475.92
    +268.82 (+1.48%)
     

  • FTSE Bursa Malaysia

    1,589.59
    +9.29 (+0.59%)
     

  • Jakarta Composite Index

    7,134.72
    -7,117.42 (-49.94%)
     

  • PSE Index

    6,615.55
    -31.00 (-0.47%)
     

Ionis to hold first quarter 2024 financial results webcast

PR Newswire
·1-min read

Webcast scheduled for Tuesday, May 7 at 11:30 a.m. Eastern Time

CARLSBAD, Calif., April 23, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Tuesday, May 7th at 11:30 a.m. Eastern Time to discuss its first quarter 2024 financial results.

Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)
Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)

The webcast may be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.

About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

ADVERTISEMENT

Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – info@ionisph.com – 760-603-2331

Ionis Pharmaceuticals Media Contact:
Hayley Soffer – CorporateCommunications@ionisph.com – 760-603-4679

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-first-quarter-2024-financial-results-webcast-302123806.html

SOURCE Ionis Pharmaceuticals, Inc.